France· FR:65156075
FLIXOTIDE DISKUS 500 microgrammes/dose, poudre pour inhalation en récipient unidose
A medicinal product containing propionate de fluticasone, registered in France by GLAXOSMITHKLINE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- PROPIONATE DE FLUTICASONE
- Manufacturer
- GLAXOSMITHKLINE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400933936327plaquette(s) PVC aluminium de 60 dose(s) avec distributeur(s) suremballée(s)/surpochée(s)EUR 20.72
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Propionate de fluticasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States24 Hour Allergy NasalWalgreen Company
- United KingdomAvamys 27.5micrograms/dose nasal sprayDE Pharmaceuticals
- FinlandAvamysOrifarm Oy
- SpainAVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASALGlaxo Group Limited
- BelgiumAerivio Spiromax 50 µg - 500 µgTeva
- NetherlandsCortifil 0,5 mg/g crèmeLaboratorios SALVAT, S.A.
- Japanフルチカゾンフランカルボン酸エステル東和薬品
- CzechiaAVAMYSGlaxoSmithKline Trading Services Limited, Dublin
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Flixonase Aquosum, Flixotide Diskus Forte
- Belgium · Flixonase Aqua, Flixotide
- Bulgaria · Аркуист, Фликсоназе
- Cyprus · Cutivate, Flixonase Aqueous
- Czechia · Flixotide Diskus, Flixotide Inhaler N
- Germany · Flutica, Fluticason Cipla
- Denmark · Flixotide, Flurhin
- Estonia · Cutivate Cream, Flixonase
- Spain · Avancort, Flixonase
- Finland · Flixonase, Flixotide Diskus
- United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
- Greece · Alerxem, Bocacort-S
- Croatia · Flixonase, Flixotide Inhaler
- Hungary · Cutivate, Flixonase
- Ireland · Arquist, Flixonase Allergy Relief
- Iceland · Avamys, Flixotide
- Italy · Aktanos, Deflut
- Liechtenstein · Avamys
- Lithuania · Cutivate, Flixotide
- Luxembourg · Flixonase Aqua, Flixotide
- Latvia · Flixonase, Flixotide
- Malta · Cutivate, Flihaler
- Netherlands · Cortifil, Cutivate
- Norway · Avamys, Flurhin
- Poland · Cutivate, Fanipos
- Portugal · Brisovent Diskus, Brisovent Inalador
- Romania · Arquist, Cutivate
- Sweden · Arquist, Fluticasone Cipla
- Slovenia · Flixonase, Flixotide
- Slovakia · Flixonase Aqueous, Flixotide Diskus
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b1b18185-b02f-4316-96b6-0b043b9b8ff8 GET /v1/drugs/b1b18185-b02f-4316-96b6-0b043b9b8ff8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65156075",
"date_amm": "1995-08-21",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "PROPIONATE DE FLUTICASONE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour inhalation",
"voies_administration": "inhalée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about propionate de fluticasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.